KC, why not focus on Oxy C patch for Ph2 as originally planned?
Why the shift to Oxy M, and others? Surely this has added to delays in Oxy C, capital allocated to Oxy C used for new projects.
POH will not have sufficient funds to complete a Ph3 if they go down this path as originally intended.
Why is a Ph2 necessary?
Suds good questions. I refer you to the last Pain ann. You will notice that with Esra deposed Harry has reset the POH commercial compass. Harry wants a Pain Portfolio that addresses a wide range of indications and therefore greatly derisks the clinical program going forward. If both Topical OxyC and Systemic OxyM get up then we have a monster commercial deal. If one trips over we still have another to get a blockbuster deal across the line. The Profile for OxyM is such that it is a more powerful opioid than OxyC and POH can see you dont need 2 drugs doing the same job in the one pain portfolio ( well thats my takeout). Meanwhile OxyC has proven in last trial to be an outstanding candidate for treatment of topical pain for which the market is currently $6-7 Billion ( compares to $3.5 Bill for OxyC systemic). The reason to conduct a Phase 2 is to establish data that a potential licensee can feel comfortable in doing a deal, It is pointless doing a massive and very expensive Phase 3 ( for which POH did admittedly raise $27 Mill at the last CR) when Big Pharma will want to do its own Phase 3 to ensure safe passsage thru the FDA. So POH actually has more than enough funds to do several Phase 2 trials at say $600,000 a pop c/f many millions for an unecessary Phase 3.
Neura Theraputic is driving this commercial path so we are in good hands imho.
- Forums
- ASX - By Stock
- AVE
- chart update
chart update, page-132
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
63 | 101422109 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 20872825 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
60 | 100172109 | 0.002 |
23 | 71850508 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 20872825 | 7 |
0.004 | 23380242 | 19 |
0.005 | 27709765 | 14 |
0.006 | 19365067 | 10 |
0.007 | 9365221 | 8 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |